28 filings
8-K
ICVX
Icosavax Inc
20 Feb 24
Completion of Acquisition or Disposition of Assets
8:42am
8-K
ICVX
Icosavax Inc
12 Dec 23
Tender and Support Agreement
4:12pm
8-K
ICVX
Icosavax Inc
14 Nov 23
Icosavax Reports Third Quarter 2023 Financial Results and Provides Corporate Update
4:17pm
8-K
ICVX
Icosavax Inc
14 Aug 23
Icosavax Reports Second Quarter 2023 Financial Results and Provides Corporate Update
4:13pm
8-K
ICVX
Icosavax Inc
8 Aug 23
Regulation FD Disclosure
4:15pm
8-K
32v541 93oe6f12
9 Jun 23
Submission of Matters to a Vote of Security Holders
4:31pm
8-K
8du0aevvda ixs
23 May 23
Entry into a Material Definitive Agreement
6:09am
8-K
yreu3 84i
22 May 23
Regulation FD Disclosure
5:12pm
8-K
w85ehc23
10 May 23
Icosavax Reports First Quarter 2023 Financial Results and Provides Corporate Update
4:18pm
8-K
dhh724wuhq9iyd
30 Mar 23
Icosavax Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update
4:14pm
8-K
4h0klhpgyy2mu4opdn
13 Dec 22
Other Events
4:13pm
8-K
91r5hh949epbaqa6tak
14 Nov 22
Icosavax Reports Third Quarter Financial Results and Provides
12:00am
8-K
h2mritf
15 Aug 22
Icosavax Reports Second Quarter 2022 Financial Results and Provides Corporate Update
4:40pm
8-K
f00hdfzi2io8lgg
28 Jun 22
Icosavax Announces Positive Topline Interim Phase 1/1b Results for VLP Vaccine Candidate IVX-121 Against RSV
4:10pm
8-K
p8x666g7zvq23c gz
15 Jun 22
Submission of Matters to a Vote of Security Holders
4:32pm
8-K
cykxj2a yav
16 May 22
Icosavax Reports First Quarter 2022 Financial Results and Provides Corporate Update
12:00am
8-K
z4edlx396 w7dd98t
25 Apr 22
Regulation FD Disclosure
8:01am
8-K
olw0krto4
30 Mar 22
Icosavax Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update
4:39pm
8-K
eq90k53
25 Mar 22
Other Events
8:09am
8-K
yn6p1db3ud
11 Feb 22
Departure of Directors or Certain Officers
5:20pm